SOAT1 and Alzheimer disease: Based on the above literature, SOCS5 expression and its mediation as a negative regulator of JAK/STAT signaling highlights the point that agents acting as agonists in enhancing SOCS5 protein expression might have therapeutic benefits in alleviating allergy-related diseases, including AD.